title: New drugs--reports of new drugs recently approved by the FDA. Alendronate.
authors.affiliation: Merck Research Laboratories, Rahway, NJ 07065-0900, USA.
authors.forename: I
authors.initials: I
authors.lastname: Shinkai
authors.forename: Y
authors.initials: Y
authors.lastname: Ohta
mesh_terms: D019386:Alendronate; D000818:Animals; D002986:Clinical Trials as Topic; D004164:Diphosphonates / Q000737:chemistry / Q000494:pharmacology / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D010001:Osteitis Deformans / Q000188:drug therapy; D015663:Osteoporosis, Postmenopausal / Q000188:drug therapy*; D051381:Rats; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D004164:Diphosphonates; D019386:Alendronate